UBE4B and neuroblastoma: In neuroblastoma patient cohorts separated by tumor stage, low UBE4B gene expression was again associated with lower relapse-free, event-free, and overall survival rates in patients with both low stage and high stage disease (Figure 2C, Supplemental Figure 1) and with stage 4 disease separately (Supplemental Figure 1).